Vivmark Residential <VMRK.N>: Barclays cuts target price to $75 from $76
VMRK•Related News

Atrium Therapeutics to Present at Wells Fargo Annual Healthcare Conference
RNA•

Palvella Therapeutics CEO to speak at Cantor Global Healthcare Conference 2026
PVLA•

Perfect Corp partners with QWEEN to launch 3D jewelry virtual try-on for Indian shoppers
PERF•

NewGenIvf Group files Form 3 for director, 10% owner Cheung Kong Yiu
NIVF•

Polyrizon completes contracts for five U.S. sites in NASARIX first-in-human seasonal allergic rhinitis trial
PLRZ•